PuraPharm Corporation Limited

HK$0.22As of Sun 8 Nov 2026, 12:00 UTC
HKEX:1498Healthcare
Country Hong Kong
PE (Fwd) •••
TSR 10Y CAGR (24.34%)
Div yield —
ROE (24.41%)
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.22
PE TTM —
TSR TTM (46.34%)
Mkt cap HK$117.7M
ROIC (1.68%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.252
14.64%
(54.25%)
Sell 4|7|2|4|8
4Q25
1Q26
2Q26
3Q26
Earnings per share$
—
—
—
—
2.08%
(7.48%)
(3.62%)
0.71%
Revenue$M
12.10
12.09
12.81
13.27
8.48%
8.24%
16.62%
14.65%
Peers (US$15.02M)
Cap (US$)
PE
15.00M
4.459x
Capital
TTM
5Y
10Y
Leveragex
0.104
0.017
0.019
EBIT/Intx
1.365
0.122
0.110
Own earn%
82.69
10.93
7.17
Sh yield%
31.32
4.08
3.66
Owners
Insiders/Inst%
0.28
51.45
Short interest%
2.11
SBC / revenue%
4.34
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
4
Op margin range%
12–16
$1 testx
−1.5
Incr. ROIC%
5